Skip to main content
Market intelligence
KRYSHealthcare

Krystal Biotech Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 25, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 25, 2026John Charles ThomasEVP, General CounselSale1,000$347.27$347,270
Jun 4, 2026Suma KrishnanPresident, R&DSale25,000$308.11$7,702,825
Jun 4, 2026Krish S KrishnanPresident and CEOSale25,000$308.12$7,702,985